Latest Breaking News On - United european gastroenterology - Page 1 : comparemela.com

Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update

Motus GI Reports First Quarter 2024 Financial Results and Provides Corporate Update
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesTroy williamsMark pomeranzCompany board of directorsExchange commissionMotus gi holdings incTrademark officeDevice divisionIsraeli ministry of healthFirst quarterProvides corporatePure vu systemChief executiveRecent businessUnited european gastroenterologyIsraeli ministry

European consortium HoloSurge secures €8 9M grant to revolutionize surgical planning with Norwegian HoloCare s 3D organ hologram technology

European consortium HoloSurge secures €8 9M grant to revolutionize surgical planning with Norwegian HoloCare s 3D organ hologram technology
arcticstartup.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arcticstartup.com Daily Mail and Mail on Sunday newspapers.

United kingdomJahn ottoDavid jayneThomas langoSemmelweis university for health technology assessmentOslo university hospitalLudwig maximilian university hospitalUniversity of leedsNetherlands cancer instituteMetropolia university of applied sciencesLeeds university teaching hospitalsCentre of excellenceHorizon europeMicrosoft hololensChief scientistOlavs hospital

Prevalence of hepatitis delta found to be high in hepatitis B surface antigen chronic carriers

Prevalence of hepatitis delta found to be high in hepatitis B surface antigen chronic carriers
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Bruxelles capitaleSaint pierreSaint pierre and miquelon generalSaint pierre and miquelonLaura weichselbaumUnited european gastroenterologyUnited european gastroenterology journal

Apraglutide Meets Primary Endpoint for Parenteral Support Reduction in Phase 3 STARS Trial

Positive topline results show apraglutide outperformed placebo for relative change from baseline in actual weekly parenteral support volume at week 24 in adults with SBS-IF.

Kishorer iyerMichael shetzlineIronwood pharmaceuticalsMount sinaiNew drug applicationPediatric intestine rehabilitationMount sinai hospitalUnited european gastroenterology

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance

– LINZESS® 2023 U.S. net sales of $1.1 billion, an increase of 7% year-over-year, driven by EUTRx prescription demand growth of 10% year-over-year – – 2023 Ironwood revenue of $443 million,.

United statesTom mccourtDrug administrationIronwood pharmaceuticals incPharmaceuticals development company incExchange commissionAbbvie incIronwood pharmaceuticals nasdaqIronwood pharmaceuticalsAmerican society for pediatric gastroenterologyFull yearBrand collaborationLancet gastroenterologyAmerican societyPediatric gastroenterologyAnnual meeting